Raphael Pharmaceutical Inc (RAPH)
1.00
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Raphael Pharmaceutical Cash from Operations (Quarterly): -0.088M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.088M |
| September 30, 2023 | -0.501M |
| June 30, 2023 | -0.215M |
| March 31, 2023 | -0.399M |
| December 31, 2022 | -0.277M |
| September 30, 2022 | -0.152M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.248M |
| March 31, 2022 | -0.082M |
| December 31, 2021 | -0.703M |
| September 30, 2021 | -0.281M |
| June 30, 2021 | -0.305M |
| March 31, 2021 | -0.129M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-0.703M
Minimum
Dec 2021
-0.082M
Maximum
Mar 2022
-0.2817M
Average
-0.2625M
Median
Cash from Operations (Quarterly) Benchmarks
| InspireMD Inc | -5.064M |
| Pluri Inc | -4.202M |
| BiomX Inc | -6.242M |
| Alpha Tau Medical Ltd | -- |
| Holdco Nuvo Group DG Ltd | -- |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.019M |
| Free Cash Flow | -1.203M |
| Free Cash Flow Per Share (Quarterly) | -0.005 |
| Free Cash Flow Yield | -7.32% |